Werewolf Therapeutics Statistics
Total Valuation
HOWL has a market cap or net worth of $35.96 million. The enterprise value is -$11.55 million.
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HOWL has 48.60 million shares outstanding. The number of shares has increased by 6.73% in one year.
| Current Share Class | 48.60M |
| Shares Outstanding | 48.60M |
| Shares Change (YoY) | +6.73% |
| Shares Change (QoQ) | +7.45% |
| Owned by Insiders (%) | 1.40% |
| Owned by Institutions (%) | 24.21% |
| Float | 41.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.45 |
| P/TBV Ratio | 1.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.38.
| Current Ratio | 1.62 |
| Quick Ratio | 1.58 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.50 |
Financial Efficiency
Return on equity (ROE) is -123.88% and return on invested capital (ROIC) is -52.41%.
| Return on Equity (ROE) | -123.88% |
| Return on Assets (ROA) | -38.63% |
| Return on Invested Capital (ROIC) | -52.41% |
| Return on Capital Employed (ROCE) | -182.50% |
| Weighted Average Cost of Capital (WACC) | 14.90% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.56M |
| Employee Count | 39 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.92% in the last 52 weeks. The beta is 0.54, so HOWL's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | -16.92% |
| 50-Day Moving Average | 0.80 |
| 200-Day Moving Average | 1.08 |
| Relative Strength Index (RSI) | 39.22 |
| Average Volume (20 Days) | 325,509 |
Short Selling Information
The latest short interest is 787,448, so 1.62% of the outstanding shares have been sold short.
| Short Interest | 787,448 |
| Short Previous Month | 1.38M |
| Short % of Shares Out | 1.62% |
| Short % of Float | 1.91% |
| Short Ratio (days to cover) | 2.48 |
Income Statement
| Revenue | n/a |
| Gross Profit | -41.73M |
| Operating Income | -60.68M |
| Pretax Income | -60.82M |
| Net Income | -60.82M |
| EBITDA | -59.04M |
| EBIT | -60.68M |
| Earnings Per Share (EPS) | -$1.33 |
Full Income StatementBalance Sheet
The company has $57.05 million in cash and $9.44 million in debt, giving a net cash position of $47.62 million or $0.98 per share.
| Cash & Cash Equivalents | 57.05M |
| Total Debt | 9.44M |
| Net Cash | 47.62M |
| Net Cash Per Share | $0.98 |
| Equity (Book Value) | 24.81M |
| Book Value Per Share | 0.51 |
| Working Capital | 22.44M |
Full Balance SheetCash Flow
| Operating Cash Flow | -60.29M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 1.63M |
| Net Borrowing | n/a |
| Free Cash Flow | -60.29M |
| FCF Per Share | -$1.24 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |